Technical Analysis for CRMD - CorMedix Inc
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Flat | Down | Flat |
| See historical CRMD trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Support | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | -0.14% | |
| Bollinger Band Squeeze | Range Contraction | -1.27% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.85% | |
| MACD Bullish Signal Line Cross | Bullish | -3.85% | |
| Bollinger Band Squeeze | Range Contraction | -3.85% | |
| BB Squeeze Started | Range Contraction | -3.85% | |
| Inside Day | Range Contraction | -3.85% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2019
- Sector: Healthcare
- Industry: Biotechnology
CorMedix Inc., a development stage pharmaceutical and medical device company, focuses on in-license, development, and commercialization of therapeutic products for the treatment of cardiac and renal dysfunction primarily in the dialysis and non-dialysis areas. It develops CRMD003 (Neutrolin), an antimicrobial/antifungal and anticoagulant combination in liquid formulation; and CRMD004, gel formulation of Neutrolin for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.
Medicine Clinical Medicine Catheters Dialysis Catheter Membrane Technology Therapeutic Products Hemodialysis Renal Dialysis Kidney Rockwell Medical Nephrology Pharmaceutical And Medical Device
Medicine Clinical Medicine Catheters Dialysis Catheter Membrane Technology Therapeutic Products Hemodialysis Renal Dialysis Kidney Rockwell Medical Nephrology Pharmaceutical And Medical Device
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more CRMD news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 13.7 |
| 52 Week Low | 0.9 |
| Average Volume | 504,090 |
| 200-Day Moving Average | 6.9885 |
| 50-Day Moving Average | 8.2814 |
| 20-Day Moving Average | 7.371 |
| 10-Day Moving Average | 7.004 |
| Average True Range | 0.4825 |
| ADX | 27.12 |
| +DI | 12.4569 |
| -DI | 23.6906 |
| Chandelier Exit (Long, 3 ATRs ) | 6.8002 |
| Chandelier Exit (Short, 3 ATRs ) | 7.8575 |
| Upper Bollinger Band | 8.2395 |
| Lower Bollinger Band | 6.5025 |
| Percent B (%b) | 0.28 |
| BandWidth | 23.565324 |
| MACD Line | -0.3921 |
| MACD Signal Line | -0.4232 |
| MACD Histogram | 0.0311 |
| Fundamentals | Value |
|---|---|
| Market Cap | 413.96 Million |
| Num Shares | 59.2 Million |
| EPS | -0.66 |
| Price-to-Earnings (P/E) Ratio | -10.67 |
| Price-to-Sales | 98.06 |
| Price-to-Book | 2.19 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.67 | ||||
| Resistance 3 (R3) | 7.64 | 7.40 | 7.55 | ||
| Resistance 2 (R2) | 7.40 | 7.22 | 7.41 | 7.51 | |
| Resistance 1 (R1) | 7.19 | 7.12 | 7.30 | 7.22 | 7.48 |
| Pivot Point | 6.95 | 6.95 | 7.00 | 6.96 | 6.95 |
| Support 1 (S1) | 6.74 | 6.77 | 6.85 | 6.77 | 6.50 |
| Support 2 (S2) | 6.50 | 6.67 | 6.51 | 6.47 | |
| Support 3 (S3) | 6.29 | 6.50 | 6.43 | ||
| Support 4 (S4) | 6.32 |
